<DOC>
	<DOCNO>NCT00802282</DOCNO>
	<brief_summary>This study investigate effect psilocybin dose frequency intensity support activity spiritual practice ( e.g. , meditation ) battery attitudinal behavioral outcome measure 75 healthy volunteer interested pursue program spiritual practice intention apply spiritual insight knowledge everyday life . After screen study enrollment , volunteer assign one five group vary dose , frequency intensity support spiritual practice , number psilocybin session ( either 2 3 session ) . The psilocybin dose manipulation double-blind . Volunteers tell session 1 , 2 , 3 , he/she could receive low , low , moderate , moderately high , high dose psilocybin . They tell participant receive 2 dose level psilocybin 2 3 session , participant one session receive moderately high high dose psilocybin . The duration volunteer 's participation approximately 6 8 month . Each volunteer receive several hour preparation study guide month prior first psilocybin session ; first two session separate one month . Various measure assess , immediately session . A battery longitudinal measure evaluate immediately study enrollment , 3 week second psilocybin session , 4 month second psilocybin session ( 6 month study enrollment ) . For purpose control expectancy 6 month follow-up evaluation , volunteer guide know volunteer many volunteer schedule third session .</brief_summary>
	<brief_title>Psilocybin Spiritual Practice</brief_title>
	<detailed_description />
	<mesh_term>Psilocybine</mesh_term>
	<criteria>Eligibility criterion volunteer receive psilocybin 21 70 year old Have give write informed consent Have high school level education Be healthy psychologically stable determine screen medical psychiatric problem via personal interview , medical questionnaire , physical examination , electrocardiogram ( ECG ) , routine medical blood urinalysis laboratory test . Have active interest explore develop spiritual life Cigarette smoker must agree abstain smoke psilocybin session day 1 hour psilocybin administration least 6 hour psilocybin administration . Agree consume approximately amount caffeinecontaining beverage ( e.g. , coffee , tea ) he/she consume usual morning , arrive research unit morning drug session day . If volunteer routinely consume caffeinated beverage , must agree session day . Agree refrain use psychoactive drug , include alcoholic beverage , within 24 hour psilocybin administration . Exceptions include caffeine nicotine . Agree take PRN medication morning psilocybin session Agree one week psilocybin session , he/she refrain take nonprescription medication , nutritional supplement , herbal supplement except approve study investigator . Exceptions evaluate study investigator include acetaminophen , nonsteroidal antiinflammatory drug , common dos vitamin mineral . General medical exclusion criterion : Women pregnant ( indicated positive urine pregnancy test assess intake drug session ) nursing ; woman childbearing potential sexually active practice effective mean birth control Cardiovascular condition : coronary artery disease , stroke , angina , uncontrolled hypertension , clinically significant ECG abnormality ( e.g. , atrial fibrillation ) , TIA past year Epilepsy history seizure Insulindependent diabetes ; take oral hypoglycemic agent , history hypoglycemia Currently take psychoactive prescription medication regular ( e.g. , daily ) basis Currently take regular ( e.g. , daily ) basis medication primary centrallyacting pharmacological effect serotonin neuron medication MAO inhibitor . For individual intermittent PRN use medication , psilocybin session conduct least 5 halflives agent elapse last dose . More 20 % outside upper low range ideal body weight Psychiatric Current past history meeting DSMIV criterion Schizophrenia , Psychotic Disorder ( unless substanceinduced due medical condition ) , Bipolar I II Disorder . Current past history within last 5 year meet DSMIV criterion alcohol drug dependence ( exclude caffeine nicotine ) severe major depression . Have first second degree relative Schizophrenia , Psychotic Disorder ( unless substance induce due medical condition ) , Bipolar I II Disorder . Currently meet DSMIV criterion Anorexia Nervosa , Bulimia Nervosa , psychiatric condition judge incompatible establishment rapport safe exposure psilocybin</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>healthy volunteer</keyword>
	<keyword>spirituality</keyword>
	<keyword>psilocybin</keyword>
	<keyword>meditation</keyword>
</DOC>